What you need to know:
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- “Speed of Thought” a documentary directed by Emmy-Award winning documentarian, Mila Aung-Thwin, explores how Verizon 5G Ultra Wideband will improve how we live, work and play. The film gives viewers an inside look at how visionaries are using advanced connectivity to tackle some of society’s biggest challenges and working on solutions that put humanity at the center of this next chapter of innovation.
From a robotic medical device that could enable doctors to perform minimally invasive heart interventions on patients thousands of miles away, to a mask that could someday allow firefighters to see through smoke, and an augmented reality learning experience that immerses students in the history of civil rights, each story within the film focuses on passionate creators exploring ways 5G will make us smarter, safer, and more compassionate.
“Consumers have a lot of questions about what 5G is and the impact it will have,” said Diego Scotti, Chief Marketing Officer, Verizon. “The truth is, 5G is going to change everything. Using this type of longform content as an educational tool gives ‘Speed of Thought’ a critical role in helping consumers understand 5G and it’s societal impact.”
The documentary will premiere today at TechCrunch Disrupt to an audience of entrepreneurs and tech leaders who are shaping the future of business and disruptive technology. The film will be available September 16 on Amazon Prime Video, Peacock and Fios on Demand.
“We are sitting on the cusp of the next industrial revolution and have a once-in-a-lifetime opportunity to completely reimagine our future,” said Tami Erwin, CEO, Verizon Business. “The innovators featured within ‘Speed of Thought’ are forging the way for life saving technology and societal advancement. There’s never been a more important time in the history of our world to innovate and build a future that’s more safe, inclusive and accessible to all.”
Saving lives in a heartbeat
Doug Teany, Chief Operating Officer at Corindus, and Dr. Ryan Madder, Interventional Cardiologist at Spectrum Health, demonstrate how Corindus’ robotic device could harness the low latency of 5G Ultra Wideband to enable a doctor to perform a robotic-assisted vascular intervention from thousands of miles away. Together, they perform the first-ever cross-country simulated telerobotic procedure in an attempt to show that the technology works and can increase access to care and and reduce time to treatment for patients.
Cing-THRU smoke
Dr. John Long, Cofounder and Chief Technology Officer at Qwake Technologies is trying to solve a problem that firefighters have faced for hundreds of years: seeing through the smoke. He’s working to create the C-THRU Mask, which he hopes will someday use augmented reality on a 5G UWB connection to allow firefighters to navigate through zero visibility conditions. The mask could also someday allow for AR video capture to be sent back to a command center, ultimately making firefighters more safe and situationally aware.
Immersive learning
Glenn Cantave, Founder and CEO, and Idris Brewster, Co-Founder and Chief Creative Officer of Movers & Shakers NYC are using immersive technology to share the stories of underrepresented communities. They are launching an augmented reality app enabled by 5G Ultra Wideband to connect students from marginalized communities with their cultural histories.
Smarter communities
Natasha Greer, IT Project Manager for the City of Sacramento is a believer that cutting edge technology will build a better future for the citizens of Sacramento. She’s currently launching a test program that uses 5G Ultra Wideband-connected cameras to collect data and adjust traffic flow in hopes to bring the rate of pedestrian accidents down to zero by 2027. Verizon engineer Derek Ohlar is a 5G expert, and is working with the University of Michigan to test a technology that uses 5G Ultra Wideband-connected cameras to help cars detect pedestrians in intersections and avoid collisions.
These innovators are working toward a more safe and connected world using Verizon 5G Ultra Wideband. In addition to watching 5G in action, “Speed of Thought” provides a brief history of wireless connectivity, as well as the importance of low latency and the role it plays in the success of next generation technologies.
For more information, visit SpeedofThoughtFilm.com
Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is celebrating its 20th year as one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $131.9 billion in 2019. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for mobility, reliable network connectivity, security and control.
VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at www.verizon.com/about/news/. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.
Media contacts:
Katie Magnotta
katie.magnotta@verizon.com
Nicole Worley
nicole.worley@verizon.com
Verizon Communications
Basking Ridge, New Jersey, UNITED STATES
verizon_logo_1300x400.jpg
Formats available:
Researchers in recent years have demonstrated the health benefits of soy, linking its consumption to reduced risk of cardiovascular disease, obesity, cancer and improved bone health.
Now, WSU researchers are hoping to use the health benefits of the popular legume to improve post-operative treatment of bone cancer.
Reporting in the journal, Acta Biomaterialia, graduate student Naboneeta Sarkar and Professor Susmita Bose in WSU's School of Mechanical and Materials Engineering showed that the slow release of soy-based chemical compounds from a 3D-printed bone-like scaffold resulted in a reduction in bone cancer cells while building up healthy cells and reducing harmful inflammation.
"There is not much research in this area of natural medicinal compounds in biomedical devices," Bose said. "Using these natural medicines, one can make a difference to human health with very minimal or no side effects, although a critical issue remains composition control."
Although rare, osteosarcoma occurs most often in children and young adults. Despite medical advances, patients with osteosarcoma and metastatic bone cancer experience a high rate of recurrence, and osteosarcoma is second leading cause of cancer death in children.
Treatment involves surgery to remove the tumor as well as pre- and post-operative chemotherapy. Large areas of bone need to be removed and repaired, and patients often experience a significant amount of inflammation during bone reconstruction, which slows healing. High doses of chemotherapy before and after surgery can also have harmful side effects.
Researchers would like to develop gentler treatment options, especially after surgery when patients are trying to recover from bone damage at the same time that they are taking harsh drugs to suppress tumor growth. Bose's team has been studying bone tissue engineering as an alternative strategy to repair the bone, using materials science principles and advanced manufacturing techniques to develop effective biomedical devices.
As part of this study, the researchers used 3D printing to make patient-specific, bone-like scaffolds that included three soy compounds and then slowly released the compounds into samples containing bone cancer as well as healthy bone cells. Soybeans contain isoflavones, plant-derived estrogens that have been shown to impede cancer cell growth for many types of cancer without being toxic to normal cells. Isoflavones have also been shown to improve bone health and possibly prevent osteoporosis.
One of the soybean compounds caused a 90% reduction in bone cancer cell viability in their samples after 11 days. Two other soy compounds, meanwhile, significantly improved the growth of healthy bone cells. Furthermore, using the soy compounds in animal models also reduced inflammation, which could benefit bone health as well as overall recovery.
"These results advance our understanding in providing therapeutic approaches in using synthetic bone grafts as a drug delivery vehicle," Bose said.
The researchers are continuing the unique area of research, studying the specific pathways of the genetic expression of natural compounds and the benefits of integrating them in biomedical technology. More detailed long-term studies are needed, using animal research as well as other malignant cells, she said.
The work was funded by the National Institutes of Health.
Story Source:
Materials provided by Washington State University. Original written by Tina Hilding. Note: Content may be edited for style and length.
Journal Reference:
Cite This Page: